Trend

Aclaris Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 34.5% during the next 3 months and, with 90% probability hold a price between $2.04 and $3.24 at the end of this period.

Signals

Aclaris Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $1.75 and $1.75. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday December 12, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

RSI14 is 66 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

Aclaris Therapeutics finds support from accumulated volume at $1.80.

Risk